Home/ENYO Pharma/Dr Pietro Scalfaro, MD, MBA
DP

Dr Pietro Scalfaro, MD, MBA

SVP Head of Clinical Development, Chief Medical Officer

ENYO Pharma

ENYO Pharma Pipeline

DrugIndicationPhase
Vonafexor (EYP001)Alport SyndromePhase 2